Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hepatitis C Treatment in Idaho County Jails
Sponsor: Eastern Idaho Public Health
Summary
To explore the feasibility of opt in Hepatitis C Virus (HCV) screening and initiation of HCV treatment during incarceration in county jails including; 1. incarcerated persons positive for HCV who remain in jail for duration of 12 weeks of treatment and 2. incarcerated persons positive for HCV in jails less than the duration of 12 weeks of treatment who receive remaining supply of study drug on discharge with appropriate linkage to care. Assess quality of life measures in participants being treated for their HCV through the validated questionnaire EuroQol-5D at baseline and post-treatment.
Official title: Screening and Treatment for Chronic Hepatitis C Infection of Persons Incarcerated in the County Jail Setting
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-08-01
Completion Date
2025-08-01
Last Updated
2024-08-01
Healthy Volunteers
No
Conditions
Interventions
sofosbuvir/velpatasvir
Patients who qualify for the study will be provided with sofosbuvir/velpatasvir for chronic hepatitis C treatment.